Cutaneous Manifestations of Strongyloidiasis

Archives of Dermatology

Volumn 124, Issue 12, 1988, Pages 1826-1830

  von Kuster, Lawrence C ^a   Genta, Robert M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TIABENDAZOLE; TICARCILLIN; TOBRAMYCIN;

ADULT; CASE REPORT; FATALITY; HISTOLOGY; HUMAN; IMMUNE DEFICIENCY; LARVA MIGRANS; MALE; NEMATODE; PRIORITY JOURNAL; PURPURA; SKIN INFECTION; STRONGYLOIDES STERCORALIS;

ANIMAL; CASE REPORT; HUMAN; IMMUNE TOLERANCE; LARVA; MALE; MIDDLE AGE; SKIN; STRONGYLOIDES; STRONGYLOIDIASIS; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0024246746     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1988.01670120042008     Document Type: Article

References (51)

1. Scowden EB, Schaffner W, Stone WJ: Overwhelming strongyloidiasis: An unappreciated opportunistic infection. Medicine 1978;57:527–544.
2. Yim Y, Kikkawa Y, Tanowitz H, et al: Fatal strongyloidiasis in Hodgkin's disease after immunosuppressive therapy. J Trop Med Hyg 1970;73:245–249.
3. Rosso R, Ricevuti G, Sessa F, et al: Fatal strongyloidiasis complicating corticosteroid therapy. Med Biol Environ 1984; 12:343–348.
4. Kalb RE, Grossman ME: Periumbilical purpura in disseminated strongyloidiasis. JAMA 1986;256:1170–1171.
5. Cruz T, Reboucas G, Rocha H: Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 1966;275:1093–1096.
6. Civantos F, Robinson MJ: Fatal strongyloidiasis following corticosteroid therapy. Am J Dig Dis 1969;14:643–651.
7. Cadham FT: Infestation with Strongyloides stercoralis associated with severe symptoms. Can Med Assoc J 1933;29:18–19.
8. Napier LE: Strongyloides stercoralis infection: II. Strongyloidiasis among ex-prisoners of war. J Trop Med Hyg 1949;52:46–48.
9. Arthur RP, Shelley WB: Larva currens: A distinct variant of cutaneous larva migrans due to Strongyloides stercoralis. Arch Dermatol 1958;78:186–190.
10. Cunliffe WJ, Silva LG: Linear urticaria due to larva currens: Strongyloidiasis. Br J Dermatol 1968;80:108–110.
11. Stone OJ, Newell GB, Mullins JF: Cutaneous strongyloidiasis: Larva currens. Arch Dermatol 1972;106:734–736.
12. Gill GV, Bell DR: Strongyloides stercoralis infection in former Far East prisoners of war. Br Med J 1979;2:572–574.
13. Corsini AC: Strongyloidiasis and chronic urticaria. Postgrad Med J 1982;58:247–248.
14. Grove DI: Treatment of strongyloidiasis with thiabendazole: An analysis of toxicity and effectiveness. Trans R Soc Trop Med Hyg 1982;76:114–118.
15. Pelletier LL: Chronic strongyloidiasis in World War II Far East ex-prisoners of war. Am J Trop Med Hyg 1984;33:55–61.
16. Pelletier LL, Gabre-Kidan T: Chronic strongyloidiasis in Vietnam veterans. Am J Med 1985;78:139–140.
17. Orecchia G, Pazzaglia A, Scaglia M, et al: Larva currens following systemic steroid therapy in a case of strongyloidiasis. Dermatologica 1985;171:366–367.
18. Scaglia M, Brustia R, Gatti S, et al: Autochthonous strongyloidiasis in Italy: An epidemiological and clinical review of 150 cases. Bull Soc Pathol Exot Filiales 1984;77:328–332.
19. Vermund SH, Lafleur F, McLeod S: Parasitic infections in a New York City hospital: Trends from 1971 to 1984. Am J Public Health 1986;76:1024–1026.
20. Smith JD, Goette DK, Odom RB: Larva currens: Cutaneous strongyloidiasis. Arch Dermatol 1976;112:1161–1163.
21. Fulleborn F: Hautquaddeln und ‘Autoinfektion’ bei Strongyloidestragen. Arch Schiffs Trop Hyg 1926;30:821.
22. Caplan JP: Creeping eruption and intestinal strongyloidiasis. Br Med J 1949;1:396.
23. Brumpt LC, Sang HT: Larva currens seul signe pathognomonique de la strongyloidose. Ann Parasitol 1973;48:319–328.
24. Grove DI: Strongyloidiasis in Allied ex-prisoners of war in Southeast Asia. Br Med J 1980;1:598–601.
25. Bezjak B: Immunoglobulin studies in strongyloidiasis with special reference to raised serum IgE levels. Am J Trop Med Hyg 1975;24:945–948.
26. Milder JE, Walzer PD, Kilgore G, et al: Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 1981;80:1481–1488.
27. Davidson RA: Strongyloidiasis: A presentation of 63 cases. NC Med J 1982;43:23–25.
28. DeMessias IT, Telles FQ, Boaretti AC, et al: Clinical, immunological and epidemiological aspects of strongyloidiasis in an endemic area of Brazil. Allergol Immunopathol 1987;15:37–41.
29. Galliard H: Pathogenesis of Strongyloides. Helminthol Abs 1967;36:247–260.
30. McLarnon M, Ma P: Brain stem glioma complicated by Strongyloides stercoralis. Ann Clin Lab Sci 1981;2:546–549.
31. Dwork KG, Jaffe JR, Lieberman HD: Strongyloidiasis with massive hyperinfection. NY State J Med 1975;75:1230–1234.
32. Sarubbi FA: Hyperinfection with Strongyloides during treatment of pemphigus vulgaris. Arch Dermatol 1987;123:864.
33. Jaramillo D, Leon W, Cardenas V, et al: Reiter's syndrome, immunodepression and strongyloidiasis: Report of a fatal case. J Cutan Pathol 1978;5:200–208.
34. Genta RM, Douce RW, Walzer PD: Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J Clin Microbiol 1986;23:1099–1103.
35. Capell-Font S, Pujol-Farriols R, Garau-Alemany J, et al: Hiperinfestacion por Strongyloides stercoralis. Med Clin 1982; 79:232–235.
36. Myers WM, Neafie RC: Creeping eruption, in Binford CH, Connor DH (eds): Pathology of Tropical and Extraordinary Diseases. Washington, DC, Armed Forces Institute of Pathology, 1976, pp 437–439.
37. Beaver PC, Jung C: Clinical Parasitology. Philadelphia, Lea & Febiger, 1984, pp 251–260.
38. Douce RW, Brown AE, Khambooruang C, et al: Seroepidemiology of strongyloidiasis in a Thai village. Int J Parasitol 1987; 17:1343–1348.
39. Sampson IA, Grove DI: Strongyloidiasis is endemic in another Australian population group: Indochinese immigrants. Med J Aust 1987;146:580–582.
40. Nutman TB, Ottesen EA, Ieng S, et al: Eosinophilia in Southeast Asian refugees: Evaluation at a referral center. J Infect Dis 1987;155:309–313.
41. Junod C: Etude retrospective de 1934 cas de strongyloidose diagnostiques a Paris: I. Origine geographique: Epidemiologie. Bull Soc Pathol Exot Filiales 1987;80:357–369.
42. Rivera E, Maldonado N, Velez-Garcia E, et al: Hyperinfection syndrome with Strongyloides stercoralis. Ann Intern Med 1970;72:199–204.
43. Davidson RA, Fletcher RH, Chapman LE: Risk factors for strongyloidiasis. Arch Intern Med 1984;144:321–324.
44. Berk SL, Verghese A, Alvarez S, et al: Clinical and epidemiological features of strongyloidiasis: A prospective study in rural Tennessee. Arch Intern Med 1987;147:1257–1261.
45. Yoeli M, Berman HH, Tesse B: I. The problem of strongyloidiasis among the mentally retarded in institutions. Trans R Soc Trop Med Hyg 1963;57:336–345.
46. Sargent RG: Parasitic infection among residents of an institution for mentally retarded persons. Am J Ment Defic 1983;87:566–569.
47. Genta RM, Weesner R, Douce RW, et al: Strongyloidiasis in US veterans of the Vietnam and other wars. JAMA 1987;258:49–52.
48. Proctor EM, Isaac-Renton J, Robertson WB, et al: Strongyloidiasis in Canadian Far East war veterans. Can Med Assoc J 1985;133:876–878.
49. Neva FA, Gam AA, Burke J: Comparison of larval antigens in an enzyme-linked immunosorbent assay for strongyloidiasis in humans. J Infect Dis 1981;144:427–432.
50. Genta RM, Weil GJ: Antibodies to Strongyloides stercoralis larval surface antigens in chronic strongyloidiasis. Lab Invest 1982;47:87–90.
51. Genta RM: Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol 1988;89:391–394.